Insider · CIK 0001938915
Thomas Von Koch
Files at DMAC (DiaMedica Therapeutics Inc.). First filing Jul 25, 2025, latest Jul 25, 2025.
In brief
Thomas Von Koch files SEC Form 4 as 10% owner at DMAC (DiaMedica Therapeutics Inc.). Since Jul 25, 2025, Thomas Von Koch has reported 1 open-market buy worth $10.0M and 0 open-market sells worth $0, the latest filed on Jul 25, 2025.
A track record needs three past buys with six months of prices behind them; Thomas Von Koch has 0, so none is measured yet.
The newest scored trade: bought $10.0M of DMAC on Jul 23, 2025, filed Jul 25, 2025, scored 57 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DMAC: DiaMedica Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | DiaMedica Therapeutics Inc. | $10.0M 2,857,142 shares | +52% | - |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 23, 2025 | DMAC DiaMedica Therapeutics Inc. | POpen-market purchase Common Sharesindirect: See Footnote 1 | +2,857,142 | $3.50 | $10.0M | 8,383,577 | Jul 25, 2025 |
Questions about Thomas Von Koch
Answered from the filings on this page, as of the latest one.
Is Thomas Von Koch buying or selling?
Not in the last 12 months. Thomas Von Koch's latest open-market trade on SEC Form 4 was bought $10.0M of DMAC on Jul 23, 2025.
How did Thomas Von Koch's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas Von Koch has 0.
Where does Thomas Von Koch file Form 4?
Thomas Von Koch has filed Form 4 at DMAC (DiaMedica Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.